| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 38.836 | 36.294 | 47.474 | 67.560 | 62.923 | 54.909 | 12.884 | - | - | - |
| Total Income - EUR | 38.857 | 36.298 | 47.477 | 67.563 | 62.929 | 54.909 | 12.884 | - | - | - |
| Total Expenses - EUR | 17.958 | 16.587 | 31.170 | 54.642 | 78.981 | 49.052 | 9.664 | - | - | - |
| Gross Profit/Loss - EUR | 20.899 | 19.711 | 16.307 | 12.921 | -16.052 | 5.856 | 3.220 | - | - | - |
| Net Profit/Loss - EUR | 19.734 | 18.708 | 14.883 | 10.894 | -17.747 | 4.450 | 2.834 | - | - | - |
| Employees | 3 | 3 | 1 | 1 | 1 | 0 | 0 | - | - | - |
Check the financial reports for the company - Biomedical Applications Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 2.288 | 1.330 | 442 | - | - | - |
| Current Assets | 60.298 | 79.606 | 93.549 | 103.131 | 87.965 | 90.920 | 93.123 | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Receivables | 10.165 | 19.395 | 18.878 | 28.333 | 22.186 | 26.318 | 28.995 | - | - | - |
| Cash | 50.133 | 60.211 | 74.671 | 74.799 | 65.779 | 64.602 | 64.128 | - | - | - |
| Shareholders Funds | 58.776 | 76.885 | 90.467 | 99.700 | 80.044 | 82.977 | 83.970 | - | - | - |
| Social Capital | 67 | 67 | 66 | 64 | 84 | 83 | 81 | - | - | - |
| Debts | 1.522 | 2.721 | 3.082 | 3.431 | 10.209 | 9.273 | 9.594 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Biomedical Applications Srl